The Controls Freaks are sponsoring and attending Midwest Association for Toxicology and Therapeutic Drug Monitoring (MATT) meeting April 12-13, 2018. We look forward to seeing you there!
Similar Post
Tianeptine: Why “Gas Station Heroin” May Be Invisible to Your Standard Panel
A patient arrives in the emergency department with pinpoint pupils, slowed breathing, and the clinical profile of an opioid overdose, yet the opioid screen comes back negative. The only clue is an empty bottle labeled Neptune’s Fix in a jacket pocket, a product the standard panel was never built to catch. Tianeptine does not show ... [Read more...]
Lot-to-Lot QC Transitions: A Practical Approach to Bridging Old and New Material
Bridging an old QC lot to a new one is fundamentally a three-part exercise: parallel testing across enough data points to characterize the new material, a defined statistical comparison against pre-set acceptance criteria, and documentation that captures the decisions made along the way. CLSI C24-Ed4 provides the underlying framework, but the practical execution depends on ... [Read more...]
The Hidden Polysubstance Problem: Gabapentinoids in Fatal Overdoses
A medical examiner signs out another fentanyl death. The scene, the prescription history, and the confirmed toxicology all point the same direction, so the case closes as a straightforward opioid overdose. The gabapentin the decedent had taken for months never reaches the report, because it was never on the confirmation panel to begin with. Gabapentin ... [Read more...]
